These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8099528)

  • 21. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
    Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
    J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
    King BL; Carter D; Foellmer HG; Kacinski BM
    Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
    Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor.
    Meden H; Kuhn W
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):173-9. PubMed ID: 9138962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
    Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
    Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms.
    Kacinski BM; Mayer AG; King BL; Carter D; Chambers SK
    Gynecol Oncol; 1992 Mar; 44(3):245-53. PubMed ID: 1347282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
    Hsieh CY; Chen CA; Chou CH; Lai KP; Jeng YM; Kuo ML; Wei LH
    J Biomed Sci; 2004; 11(2):249-59. PubMed ID: 14966375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of p105 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma.
    Marx D; Fattahi-Meibodi A; Kudelka R; Uebel T; Kuhn W; Meden H
    Anticancer Res; 1998; 18(4B):2891-4. PubMed ID: 9713482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interferons on the expression of the proto-oncogene HER-2 in human ovarian carcinoma cells.
    Marth C; Cronauer MV; Doppler W; Ofner D; Ullrich A; Daxenbichler G
    Int J Cancer; 1992 Jan; 50(1):64-8. PubMed ID: 1370227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
    Marth C; Müller-Holzner E; Greiter E; Cronauer MV; Zeimet AG; Doppler W; Eibl B; Hynes NE; Daxenbichler G
    Cancer Res; 1990 Nov; 50(21):7037-41. PubMed ID: 2119884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
    Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J
    Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
    Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
    Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
    Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
    J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neu oncogene expression in ovarian tumors: a quantitative study.
    Huettner PC; Carney WP; Naber SP; DeLellis RA; Membrino W; Wolfe HJ
    Mod Pathol; 1992 May; 5(3):250-6. PubMed ID: 1353878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma.
    Sasaki N; Kudoh K; Kita T; Tsuda H; Furuya K; Kikuchi Y
    J Obstet Gynaecol Res; 2007 Feb; 33(1):17-23. PubMed ID: 17212661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell growth regulation in epithelial ovarian cancer.
    Bast RC; Boyer CM; Jacobs I; Xu FJ; Wu S; Wiener J; Kohler M; Berchuck A
    Cancer; 1993 Feb; 71(4 Suppl):1597-601. PubMed ID: 8431895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.